Anluohuaxian is recommended for the treatment of liver fibrosis in China. Anluo-huaxian is known to suppress the expression of type I and III collagen mRNAs, the tissue inhibitor of matrix metalloprotease-1 (TIMP-1) and TGF-β1 in patients with liver fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.